The global LFA-based Cardiac market size was valued at USD 3699.5 million in 2022 and is forecast to a readjusted size of USD 6161.8 million by 2029 with a CAGR of 7.6% during review period.
Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
The industry's leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.
This report is a detailed and comprehensive analysis for global LFA-based Cardiac market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global LFA-based Cardiac market size and forecasts, in consumption value ($ Million), 2018-2029
Global LFA-based Cardiac market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global LFA-based Cardiac market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global LFA-based Cardiac market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for LFA-based Cardiac
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global LFA-based Cardiac market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
Troponin I
Troponin T
CK-MB
Myoglobin
Others
Laboratory Testing
Point-of-care Testing
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe LFA-based Cardiac product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of LFA-based Cardiac, with revenue, gross margin and global market share of LFA-based Cardiac from 2018 to 2023.
Chapter 3, the LFA-based Cardiac competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and LFA-based Cardiac market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of LFA-based Cardiac.
Chapter 13, to describe LFA-based Cardiac research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of LFA-based Cardiac
1.2 Market Estimation Caveats and Base Year
1.3 Classification of LFA-based Cardiac by Type
1.3.1 Overview: Global LFA-based Cardiac Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global LFA-based Cardiac Consumption Value Market Share by Type in 2022
1.3.3 Troponin I
1.3.4 Troponin T
1.3.5 CK-MB
1.3.6 Myoglobin
1.3.7 Others
1.4 Global LFA-based Cardiac Market by Application
1.4.1 Overview: Global LFA-based Cardiac Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Laboratory Testing
1.4.3 Point-of-care Testing
1.5 Global LFA-based Cardiac Market Size & Forecast
1.6 Global LFA-based Cardiac Market Size and Forecast by Region
1.6.1 Global LFA-based Cardiac Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global LFA-based Cardiac Market Size by Region, (2018-2029)
1.6.3 North America LFA-based Cardiac Market Size and Prospect (2018-2029)
1.6.4 Europe LFA-based Cardiac Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific LFA-based Cardiac Market Size and Prospect (2018-2029)
1.6.6 South America LFA-based Cardiac Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa LFA-based Cardiac Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche LFA-based Cardiac Product and Solutions
2.1.4 Roche LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott LFA-based Cardiac Product and Solutions
2.2.4 Abbott LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbott Recent Developments and Future Plans
2.3 Siemens
2.3.1 Siemens Details
2.3.2 Siemens Major Business
2.3.3 Siemens LFA-based Cardiac Product and Solutions
2.3.4 Siemens LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Siemens Recent Developments and Future Plans
2.4 Danaher
2.4.1 Danaher Details
2.4.2 Danaher Major Business
2.4.3 Danaher LFA-based Cardiac Product and Solutions
2.4.4 Danaher LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Danaher Recent Developments and Future Plans
2.5 Bio-Rad Laboratories
2.5.1 Bio-Rad Laboratories Details
2.5.2 Bio-Rad Laboratories Major Business
2.5.3 Bio-Rad Laboratories LFA-based Cardiac Product and Solutions
2.5.4 Bio-Rad Laboratories LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.6 BioMérieux
2.6.1 BioMérieux Details
2.6.2 BioMérieux Major Business
2.6.3 BioMérieux LFA-based Cardiac Product and Solutions
2.6.4 BioMérieux LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BioMérieux Recent Developments and Future Plans
2.7 Thermo Fisher
2.7.1 Thermo Fisher Details
2.7.2 Thermo Fisher Major Business
2.7.3 Thermo Fisher LFA-based Cardiac Product and Solutions
2.7.4 Thermo Fisher LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Thermo Fisher Recent Developments and Future Plans
2.8 Ortho Clinical Diagnostics
2.8.1 Ortho Clinical Diagnostics Details
2.8.2 Ortho Clinical Diagnostics Major Business
2.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Product and Solutions
2.8.4 Ortho Clinical Diagnostics LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
2.9 LSI Medience Corporation
2.9.1 LSI Medience Corporation Details
2.9.2 LSI Medience Corporation Major Business
2.9.3 LSI Medience Corporation LFA-based Cardiac Product and Solutions
2.9.4 LSI Medience Corporation LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 LSI Medience Corporation Recent Developments and Future Plans
2.10 Randox laboratories
2.10.1 Randox laboratories Details
2.10.2 Randox laboratories Major Business
2.10.3 Randox laboratories LFA-based Cardiac Product and Solutions
2.10.4 Randox laboratories LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Randox laboratories Recent Developments and Future Plans
2.11 Wondfo Biotech
2.11.1 Wondfo Biotech Details
2.11.2 Wondfo Biotech Major Business
2.11.3 Wondfo Biotech LFA-based Cardiac Product and Solutions
2.11.4 Wondfo Biotech LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Wondfo Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global LFA-based Cardiac Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of LFA-based Cardiac by Company Revenue
3.2.2 Top 3 LFA-based Cardiac Players Market Share in 2022
3.2.3 Top 6 LFA-based Cardiac Players Market Share in 2022
3.3 LFA-based Cardiac Market: Overall Company Footprint Analysis
3.3.1 LFA-based Cardiac Market: Region Footprint
3.3.2 LFA-based Cardiac Market: Company Product Type Footprint
3.3.3 LFA-based Cardiac Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global LFA-based Cardiac Consumption Value and Market Share by Type (2018-2023)
4.2 Global LFA-based Cardiac Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global LFA-based Cardiac Consumption Value Market Share by Application (2018-2023)
5.2 Global LFA-based Cardiac Market Forecast by Application (2024-2029)
6 North America
6.1 North America LFA-based Cardiac Consumption Value by Type (2018-2029)
6.2 North America LFA-based Cardiac Consumption Value by Application (2018-2029)
6.3 North America LFA-based Cardiac Market Size by Country
6.3.1 North America LFA-based Cardiac Consumption Value by Country (2018-2029)
6.3.2 United States LFA-based Cardiac Market Size and Forecast (2018-2029)
6.3.3 Canada LFA-based Cardiac Market Size and Forecast (2018-2029)
6.3.4 Mexico LFA-based Cardiac Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe LFA-based Cardiac Consumption Value by Type (2018-2029)
7.2 Europe LFA-based Cardiac Consumption Value by Application (2018-2029)
7.3 Europe LFA-based Cardiac Market Size by Country
7.3.1 Europe LFA-based Cardiac Consumption Value by Country (2018-2029)
7.3.2 Germany LFA-based Cardiac Market Size and Forecast (2018-2029)
7.3.3 France LFA-based Cardiac Market Size and Forecast (2018-2029)
7.3.4 United Kingdom LFA-based Cardiac Market Size and Forecast (2018-2029)
7.3.5 Russia LFA-based Cardiac Market Size and Forecast (2018-2029)
7.3.6 Italy LFA-based Cardiac Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific LFA-based Cardiac Consumption Value by Type (2018-2029)
8.2 Asia-Pacific LFA-based Cardiac Consumption Value by Application (2018-2029)
8.3 Asia-Pacific LFA-based Cardiac Market Size by Region
8.3.1 Asia-Pacific LFA-based Cardiac Consumption Value by Region (2018-2029)
8.3.2 China LFA-based Cardiac Market Size and Forecast (2018-2029)
8.3.3 Japan LFA-based Cardiac Market Size and Forecast (2018-2029)
8.3.4 South Korea LFA-based Cardiac Market Size and Forecast (2018-2029)
8.3.5 India LFA-based Cardiac Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia LFA-based Cardiac Market Size and Forecast (2018-2029)
8.3.7 Australia LFA-based Cardiac Market Size and Forecast (2018-2029)
9 South America
9.1 South America LFA-based Cardiac Consumption Value by Type (2018-2029)
9.2 South America LFA-based Cardiac Consumption Value by Application (2018-2029)
9.3 South America LFA-based Cardiac Market Size by Country
9.3.1 South America LFA-based Cardiac Consumption Value by Country (2018-2029)
9.3.2 Brazil LFA-based Cardiac Market Size and Forecast (2018-2029)
9.3.3 Argentina LFA-based Cardiac Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa LFA-based Cardiac Consumption Value by Type (2018-2029)
10.2 Middle East & Africa LFA-based Cardiac Consumption Value by Application (2018-2029)
10.3 Middle East & Africa LFA-based Cardiac Market Size by Country
10.3.1 Middle East & Africa LFA-based Cardiac Consumption Value by Country (2018-2029)
10.3.2 Turkey LFA-based Cardiac Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia LFA-based Cardiac Market Size and Forecast (2018-2029)
10.3.4 UAE LFA-based Cardiac Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 LFA-based Cardiac Market Drivers
11.2 LFA-based Cardiac Market Restraints
11.3 LFA-based Cardiac Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 LFA-based Cardiac Industry Chain
12.2 LFA-based Cardiac Upstream Analysis
12.3 LFA-based Cardiac Midstream Analysis
12.4 LFA-based Cardiac Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global LFA-based Cardiac Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global LFA-based Cardiac Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global LFA-based Cardiac Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global LFA-based Cardiac Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche LFA-based Cardiac Product and Solutions
Table 8. Roche LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Abbott Company Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott LFA-based Cardiac Product and Solutions
Table 13. Abbott LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abbott Recent Developments and Future Plans
Table 15. Siemens Company Information, Head Office, and Major Competitors
Table 16. Siemens Major Business
Table 17. Siemens LFA-based Cardiac Product and Solutions
Table 18. Siemens LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Siemens Recent Developments and Future Plans
Table 20. Danaher Company Information, Head Office, and Major Competitors
Table 21. Danaher Major Business
Table 22. Danaher LFA-based Cardiac Product and Solutions
Table 23. Danaher LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Danaher Recent Developments and Future Plans
Table 25. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 26. Bio-Rad Laboratories Major Business
Table 27. Bio-Rad Laboratories LFA-based Cardiac Product and Solutions
Table 28. Bio-Rad Laboratories LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bio-Rad Laboratories Recent Developments and Future Plans
Table 30. BioMérieux Company Information, Head Office, and Major Competitors
Table 31. BioMérieux Major Business
Table 32. BioMérieux LFA-based Cardiac Product and Solutions
Table 33. BioMérieux LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. BioMérieux Recent Developments and Future Plans
Table 35. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Major Business
Table 37. Thermo Fisher LFA-based Cardiac Product and Solutions
Table 38. Thermo Fisher LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Thermo Fisher Recent Developments and Future Plans
Table 40. Ortho Clinical Diagnostics Company Information, Head Office, and Major Competitors
Table 41. Ortho Clinical Diagnostics Major Business
Table 42. Ortho Clinical Diagnostics LFA-based Cardiac Product and Solutions
Table 43. Ortho Clinical Diagnostics LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Ortho Clinical Diagnostics Recent Developments and Future Plans
Table 45. LSI Medience Corporation Company Information, Head Office, and Major Competitors
Table 46. LSI Medience Corporation Major Business
Table 47. LSI Medience Corporation LFA-based Cardiac Product and Solutions
Table 48. LSI Medience Corporation LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. LSI Medience Corporation Recent Developments and Future Plans
Table 50. Randox laboratories Company Information, Head Office, and Major Competitors
Table 51. Randox laboratories Major Business
Table 52. Randox laboratories LFA-based Cardiac Product and Solutions
Table 53. Randox laboratories LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Randox laboratories Recent Developments and Future Plans
Table 55. Wondfo Biotech Company Information, Head Office, and Major Competitors
Table 56. Wondfo Biotech Major Business
Table 57. Wondfo Biotech LFA-based Cardiac Product and Solutions
Table 58. Wondfo Biotech LFA-based Cardiac Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Wondfo Biotech Recent Developments and Future Plans
Table 60. Global LFA-based Cardiac Revenue (USD Million) by Players (2018-2023)
Table 61. Global LFA-based Cardiac Revenue Share by Players (2018-2023)
Table 62. Breakdown of LFA-based Cardiac by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in LFA-based Cardiac, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key LFA-based Cardiac Players
Table 65. LFA-based Cardiac Market: Company Product Type Footprint
Table 66. LFA-based Cardiac Market: Company Product Application Footprint
Table 67. LFA-based Cardiac New Market Entrants and Barriers to Market Entry
Table 68. LFA-based Cardiac Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global LFA-based Cardiac Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global LFA-based Cardiac Consumption Value Share by Type (2018-2023)
Table 71. Global LFA-based Cardiac Consumption Value Forecast by Type (2024-2029)
Table 72. Global LFA-based Cardiac Consumption Value by Application (2018-2023)
Table 73. Global LFA-based Cardiac Consumption Value Forecast by Application (2024-2029)
Table 74. North America LFA-based Cardiac Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America LFA-based Cardiac Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America LFA-based Cardiac Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America LFA-based Cardiac Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America LFA-based Cardiac Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America LFA-based Cardiac Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe LFA-based Cardiac Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe LFA-based Cardiac Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe LFA-based Cardiac Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe LFA-based Cardiac Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe LFA-based Cardiac Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe LFA-based Cardiac Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific LFA-based Cardiac Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific LFA-based Cardiac Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific LFA-based Cardiac Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific LFA-based Cardiac Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific LFA-based Cardiac Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific LFA-based Cardiac Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America LFA-based Cardiac Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America LFA-based Cardiac Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America LFA-based Cardiac Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America LFA-based Cardiac Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America LFA-based Cardiac Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America LFA-based Cardiac Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa LFA-based Cardiac Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa LFA-based Cardiac Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa LFA-based Cardiac Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa LFA-based Cardiac Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa LFA-based Cardiac Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa LFA-based Cardiac Consumption Value by Country (2024-2029) & (USD Million)
Table 104. LFA-based Cardiac Raw Material
Table 105. Key Suppliers of LFA-based Cardiac Raw Materials
List of Figures
Figure 1. LFA-based Cardiac Picture
Figure 2. Global LFA-based Cardiac Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global LFA-based Cardiac Consumption Value Market Share by Type in 2022
Figure 4. Troponin I
Figure 5. Troponin T
Figure 6. CK-MB
Figure 7. Myoglobin
Figure 8. Others
Figure 9. Global LFA-based Cardiac Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. LFA-based Cardiac Consumption Value Market Share by Application in 2022
Figure 11. Laboratory Testing Picture
Figure 12. Point-of-care Testing Picture
Figure 13. Global LFA-based Cardiac Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global LFA-based Cardiac Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market LFA-based Cardiac Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global LFA-based Cardiac Consumption Value Market Share by Region (2018-2029)
Figure 17. Global LFA-based Cardiac Consumption Value Market Share by Region in 2022
Figure 18. North America LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 21. South America LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 23. Global LFA-based Cardiac Revenue Share by Players in 2022
Figure 24. LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players LFA-based Cardiac Market Share in 2022
Figure 26. Global Top 6 Players LFA-based Cardiac Market Share in 2022
Figure 27. Global LFA-based Cardiac Consumption Value Share by Type (2018-2023)
Figure 28. Global LFA-based Cardiac Market Share Forecast by Type (2024-2029)
Figure 29. Global LFA-based Cardiac Consumption Value Share by Application (2018-2023)
Figure 30. Global LFA-based Cardiac Market Share Forecast by Application (2024-2029)
Figure 31. North America LFA-based Cardiac Consumption Value Market Share by Type (2018-2029)
Figure 32. North America LFA-based Cardiac Consumption Value Market Share by Application (2018-2029)
Figure 33. North America LFA-based Cardiac Consumption Value Market Share by Country (2018-2029)
Figure 34. United States LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe LFA-based Cardiac Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe LFA-based Cardiac Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe LFA-based Cardiac Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 41. France LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific LFA-based Cardiac Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific LFA-based Cardiac Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific LFA-based Cardiac Consumption Value Market Share by Region (2018-2029)
Figure 48. China LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 51. India LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 54. South America LFA-based Cardiac Consumption Value Market Share by Type (2018-2029)
Figure 55. South America LFA-based Cardiac Consumption Value Market Share by Application (2018-2029)
Figure 56. South America LFA-based Cardiac Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa LFA-based Cardiac Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa LFA-based Cardiac Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa LFA-based Cardiac Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE LFA-based Cardiac Consumption Value (2018-2029) & (USD Million)
Figure 65. LFA-based Cardiac Market Drivers
Figure 66. LFA-based Cardiac Market Restraints
Figure 67. LFA-based Cardiac Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of LFA-based Cardiac in 2022
Figure 70. Manufacturing Process Analysis of LFA-based Cardiac
Figure 71. LFA-based Cardiac Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
